drugset / Trial / NCT02216253
L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will include women who will undergo pelvic reconstructive surgery and/or anti-incontinence sling procedures. Patients will be randomized to the combination of L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract in tablet or placebo twice a day during the seven days before and after surgery (total of 14 days). In this randomized, double-blind study, the investigators will assess treatment of clinically suspected or culture-proven urinary tract infections within 3 weeks of surgery (primary outcome), and risk factors for treatment for postoperative urinary tract infections (secondary outcomes) between the two study groups.
Timeline
- Start
- 2014-10
- Primary completion
- 2015-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Boswellia Leaf Extract | Unknown | — | — |
| Comparator | Hibiscus Sabdariffa | Traditional medicine (herbal / TCM) | — | — |
| Comparator | amino acids | Unknown | — | — |